These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 666109)

  • 1. The relative drug susceptibility of opaque colonial forms of Mycobacterium intracellulare-avium: does it affect therapeutic results?
    Moulding T
    Am Rev Respir Dis; 1978 Jun; 117(6):1142-3. PubMed ID: 666109
    [No Abstract]   [Full Text] [Related]  

  • 2. [A study on drug regimens against Mycobacterium avium-intracellulare infection (3). The therapeutic effect of some antimicrobial agents to murine infection model].
    Sakurai N
    Kekkaku; 1988 Jun; 63(6):447-60. PubMed ID: 3172623
    [No Abstract]   [Full Text] [Related]  

  • 3. Tuberculostatic effect in vitro of certain new antibiotics (amikin, dalacin C, clindamycin, netromycin, tobramycin, lincomycin) on mycobacteria, particularly on M. avium.
    Sula L; Sulová J
    Czech Med; 1984; 7(2):122-8. PubMed ID: 6430657
    [No Abstract]   [Full Text] [Related]  

  • 4. [Treatment and prognosis in cases of M. avium-intracellulare infection].
    Kekkaku; 1987 Nov; 62(11):575-601. PubMed ID: 3444198
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bacteriostatic effects of sulfadimethoxine and kitasamycin on Mycobacterium avium-M. intracellulare complex].
    Tsukamura M
    Kekkaku; 1983 Apr; 58(4):247-50. PubMed ID: 6632486
    [No Abstract]   [Full Text] [Related]  

  • 6. [In vitro susceptibilities of Mycobacterium avium and Mycobacterium intracellulare to various drugs].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1991 Jul; 66(7):489-92. PubMed ID: 1890791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlations among naturally occurring resistances to antituberculosis drugs in Mycobacterium avium complex strains.
    Tsukamura M; Miyachi T
    Am Rev Respir Dis; 1989 Apr; 139(4):1033-5. PubMed ID: 2930064
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variation in isoniazid susceptibility of Mycobacterium avium during the cell cycle.
    McCarthy CM
    Am Rev Respir Dis; 1981 Apr; 123(4 Pt 1):450-3. PubMed ID: 7224357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Sensitivity of Mycobacterium intracellulare and Mycobacterium kansasii to antituberculous drugs].
    Zhao T; Yang SR
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1986 Dec; 9(6):359-60, 383. PubMed ID: 3582058
    [No Abstract]   [Full Text] [Related]  

  • 10. In vitro susceptibility of Mycobacterium fortuitum, Mycobacterium chelonae and Mycobacterium avium against some quinolones.
    Casal M; Rodriguez F; Villalba R; Benavente MC; Gonzalez AI
    Chemioterapia; 1987 Dec; 6(6):431-3. PubMed ID: 3481302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uptake of selected antibacterial agents in Mycobacterium avium.
    David HL; Clavel-Seres S; Clement F; Goh KS
    Zentralbl Bakteriol Mikrobiol Hyg A; 1987 Jul; 265(3-4):385-92. PubMed ID: 3673344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility of human and environmental isolates of Mycobacterium avium, M. intracellulare, and M. scrofulaceum to heavy-metal salts and oxyanions.
    Falkinham JO; George KL; Parker BC; Gruft H
    Antimicrob Agents Chemother; 1984 Jan; 25(1):137-9. PubMed ID: 6230989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rapid radiometric method for determining drug susceptibility of Mycobacterium avium-intracellulare.
    Yangco BG; Eikman EA; Solomon DA; Deresinski SC; Madden JA
    Antimicrob Agents Chemother; 1981 Apr; 19(4):534-9. PubMed ID: 7247376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and antimycobacterial activity of some 4-pyridinecarboxyamidrazone derivatives.
    Mamolo MG; Vio L; Banfi E; Predominato M; Fabris C; Asaro F
    Farmaco; 1993 Apr; 48(4):529-38. PubMed ID: 8357468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [In vitro sensitivity of Mycobacterium avium and Mycobacterium xenopi to erythromycin, roxithromycin and doxycycline].
    Maugein J; Fourche J; Mormede M; Pellegrin JL
    Pathol Biol (Paris); 1989 Jun; 37(5 Pt 2):565-7. PubMed ID: 2797881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [In vitro antimycobacterial activity of clarithromycin and its therapeutic efficacy against Mycobacterium intracellulare infection induced in mice].
    Tomioka H; Sato K; Saito H
    Kekkaku; 1993 Apr; 68(4):293-9. PubMed ID: 8497119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility of Mycobacterium avium complex and Mycobacterium tuberculosis strains to a spiro-piperidyl rifamycin.
    Woodley CL; Kilburn JO
    Am Rev Respir Dis; 1982 Sep; 126(3):586-7. PubMed ID: 6289711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activity of capuramycin analogues against Mycobacterium tuberculosis, Mycobacterium avium and Mycobacterium intracellulare in vitro and in vivo.
    Koga T; Fukuoka T; Doi N; Harasaki T; Inoue H; Hotoda H; Kakuta M; Muramatsu Y; Yamamura N; Hoshi M; Hirota T
    J Antimicrob Chemother; 2004 Oct; 54(4):755-60. PubMed ID: 15347635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-tubercular agents. Part 3. Benzothiadiazine as a novel scaffold for anti-Mycobacterium activity.
    Kamal A; Reddy KS; Ahmed SK; Khan MN; Sinha RK; Yadav JS; Arora SK
    Bioorg Med Chem; 2006 Feb; 14(3):650-8. PubMed ID: 16203154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.